OGI
What one share of Organigram Holdings holds
Pharmaceutical Preparations
Organigram Holdings’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-09-30; the balance sheet is as of 2025-09-30.
| Sales | $1.45 |
|---|---|
| Profit | −$0.14 |
| Capex (buildings and equipment) | $0.10 |
| Free cash flow | −$0.14 |
| Cash and investments | $0.45 |
| Debt | $0.00 |
| Book value | $1.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $0.31 | $0.51 | $1.39 | −$1.71 | — | $4.51 |
| 2019 | $1.60 | −$0.20 | $2.17 | −$2.86 | — | $6.30 |
| 2020 | $1.45 | −$2.34 | $1.29 | −$2.04 | — | $4.73 |
| 2021 | $0.98 | −$1.61 | $0.14 | −$0.50 | — | $5.09 |
| 2022 | $1.48 | −$0.15 | $0.50 | −$0.86 | — | $4.95 |
| 2024 | $1.23 | −$0.35 | $0.04 | −$0.01 | — | $2.09 |
| 2025 | $1.45 | −$0.14 | $0.10 | −$0.14 | — | $1.86 |